ロード中...

Direct‐acting antivirals for chronic hepatitis C

BACKGROUND: Millions of people worldwide suffer from hepatitis C, which can lead to severe liver disease, liver cancer, and death. Direct‐acting antivirals (DAAs) are relatively new and expensive interventions for chronic hepatitis C, and preliminary results suggest that DAAs may eradicate hepatitis...

詳細記述

保存先:
書誌詳細
出版年:Cochrane Database Syst Rev
主要な著者: Jakobsen, Janus C, Nielsen, Emil Eik, Feinberg, Joshua, Katakam, Kiran Kumar, Fobian, Kristina, Hauser, Goran, Poropat, Goran, Djurisic, Snezana, Weiss, Karl Heinz, Bjelakovic, Milica, Bjelakovic, Goran, Klingenberg, Sarah Louise, Liu, Jian Ping, Nikolova, Dimitrinka, Koretz, Ronald L, Gluud, Christian
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley & Sons, Ltd 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6484383/
https://ncbi.nlm.nih.gov/pubmed/28585310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012143.pub2
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!